Daytime Intragastric pH With Esomeprazole 20 mg: New Comparative Analyses With Other Proton Pump Inhibitors Omeprazole 20 mg, Lansoprazole 15 mg, and Pantoprazole 20 mg
Philip O. Katz(Cornell University), David B. Johnson(Eastern Virginia Medical School), Tore Lind(Skaraborg Hospital), Barry Traxler(AstraZeneca (United States)), Peter J. Kahrilas(Northwestern University), John Dent(Royal Adelaide Hospital), Kerstin Röhss(AstraZeneca (Sweden))
Cited by 0
Related Papers
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
|Gastroenterology|1988|786
American Gastroenterological Association Medical Position Statement on the Management of Gastroesophageal Reflux Disease
|Gastroenterology|2008|698